Business
Sino Biological Launches XPressMAX™ Cell-Free Protein Synthesis Kit, Accelerating AI-Powered High-Throughput Antibody Drug Discovery
Sino Biological, Inc. (Shenzhen Stock Exchange: 301047.SZ), a global leader in recombinant technology, is proud to announce the launch of its innovative XPressMAX™ Cell-Free Protein Synthesis Kit (Cat#: CFKIT02), a cutting-edge solution designed to supercharge artificial intelligence (AI)-driven high-throughput screening pipelines for antibody drug discovery.
About this update from Sino Biological Inc. Class A
[{"type":"text","content":"Ultra-Fast Protein/Antibody Synthesis in 3 Hours, Speed Up AI-Powered HTP Screening","length":83,"tagName":"p"},{"type":"text","content":"HOUSTON, May 19, 2026 /PRNewswire/ -- Sino Biological, Inc. (Shenzhen Stock Exchange: 301047.SZ), a global leader in recombinant technology, is proud to announce the launch of its innovative XPressMAX™ Cell-Free Protein Synthesis Kit (Cat#: CFKIT02), a cutting-edge solution designed to supercharge artificial intelligence (AI)-driven high-throughput screening pipelines for antibody drug discovery.","length":404,"tagName":"p"},{"type":"image","alt":"XPressMAX™ Cell-Free Protein Synthesis Kit","displaySize":"","headline":null,"caption":"XPressMAX™ Cell-Free Protein Synthesis Kit","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/5a8a05cffc24bf6498791d991518da5d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/mmnssMgCbAyUyo_Io41NSw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNQ--/https://media.zenfs.com/en/prnewswire.com/5a8a05cffc24bf6498791d991518da5d","width":400,"height":400},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/8e9nWj4OFL3w0CQ1FWkRVg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTY0MA--/https://media.zenfs.com/en/prnewswire.com/5a8a05cffc24bf6498791d991518da5d","width":400,"height":400}},"href":"https://mma.prnewswire.com/media/2982830/1200_1200.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"XPressMAX™ Cell-Free Protein Synthesis Kit","length":42,"tagName":"p"},{"type":"text","content":"The novel kit leverages advanced cell-free protein synthesis technology to enable rapid, efficient in vitro production of target proteins and antibodies—eliminating the constraints of traditional cell-based expression systems. By seamlessly integrating with AI-powered screening platforms, the kit helps researchers accelerate the identification and optimization of antibody candidates, reducing both development timelines and costs.","length":433,"tagName":"p"},{"type":"text","content":"Based on an E. coli lysate and fully supplemented with essential transcription and translation components, XPressMAX™ enables direct protein synthesis from plasmid or PCR templates. Designed for antibody drug discovery, XPressMAX™ enables rapid expression and validation of VHH, scFv, Fab, and Miniprotei...